"""
ALGORITHM: HGH_Hormone -- "Somatotropic Signal Amplification"
==============================================================
Straps Human Growth Hormone signaling cascade to the most positive
domesticated TEs, then routes the amplified signal through quantum
compute for trade decisions.

Molecular basis:
    Human Growth Hormone (HGH / Somatotropin)
    Empirical formula: C990H1529N263O299S7
    Molecular weight:  22,124 Da (22-kDa variant, 191 amino acids)
    Structure:         Four-helix bundle ("up-up-down-down" topology)
    Disulfide bridges: Cys-53 <-> Cys-165, Cys-182 <-> Cys-189

    HGH does NOT enter cells. It acts as an extracellular signal that
    triggers a relay cascade:

    1. RECEPTOR DIMERIZATION (the "handshake"):
       A single HGH molecule has TWO binding sites (Site 1 and Site 2).
       It binds one GH receptor (GHR), then recruits a SECOND receptor.
       This 1:2 ratio -- one ligand bringing two receptors together --
       is the activation trigger. Without dimerization, nothing happens.

    2. JAK2/STAT PATHWAY (the relay):
       Dimerized receptors activate JAK2 kinase, which phosphorylates
       the receptors. STAT proteins (Signal Transducers and Activators
       of Transcription) dock onto these phosphates, then translocate
       to the nucleus to activate growth genes.

    3. DIRECT EFFECTS (lipolysis):
       HGH binds adipocyte receptors directly, signaling fat breakdown
       (triglyceride hydrolysis) and suppressing lipid uptake.

    4. INDIRECT EFFECTS (IGF-1 bridge):
       HGH -> liver -> IGF-1 production -> IGF-1 travels to muscle/bone.
       IGF-1 drives the actual growth: myoblast proliferation (muscle),
       chondrocyte activity (bone), collagen synthesis (tissue repair).
       Most "growth" attributed to HGH is actually performed by IGF-1.

    5. NEGATIVE FEEDBACK:
       High IGF-1 -> suppresses pituitary HGH release (GHIH/somatostatin).
       Prevents runaway growth. Loss of this feedback = acromegaly.

    6. PULSATILE SECRETION:
       HGH is released in discrete pulses (largest during deep sleep).
       Continuous HGH paradoxically downregulates receptors (tachyphylaxis).
       Pulsatile delivery is CRITICAL for effectiveness.

Trading analogy -- "Somatotropic Signal Amplification":

    The DOMESTICATED TE is the growth hormone receptor (GHR).
    The HGH MOLECULE is a market confidence signal built from the
    strongest domesticated TE patterns. The hormone "straps" to the
    top-performing TEs and amplifies their signal through a multi-stage
    cascade before it hits the quantum circuit.

    Phase 1 - FOUR-HELIX BUNDLE CONSTRUCTION (Hormone Synthesis):
        Query the domestication database for all TEs with:
          - domesticated = TRUE
          - posterior_wr >= 0.70
          - profit_factor >= 1.5
          - last_activated within DOMESTICATION_EXPIRY_DAYS
        Rank by composite fitness = posterior_wr * log(profit_factor + 1).
        Select TOP 4 TEs. These form the four-helix bundle:
          Helix A (up):   Strongest TE     -- primary signal
          Helix B (up):   2nd strongest TE  -- confirming signal
          Helix C (down): 3rd strongest TE  -- counter-signal (diversity)
          Helix D (down): 4th strongest TE  -- stabilizing signal
        The "up-up-down-down" topology ensures the hormone isn't just
        an echo chamber. Helices C and D may hold SHORT-biased or
        mean-reversion TEs that balance the growth signal.

    Phase 2 - DISULFIDE BRIDGE VALIDATION (Structural Integrity):
        Two disulfide bridges must hold for the hormone to be active:
          Bridge 1 (Cys-53 <-> Cys-165):
            Helix A and Helix C must agree on VOLATILITY REGIME.
            Both must classify current regime as the same state
            (trending, ranging, or volatile). If they disagree, the
            hormone misfolds and is discarded (no amplification).
          Bridge 2 (Cys-182 <-> Cys-189):
            Helix B and Helix D must agree on DIRECTION.
            The net directional vote of B and D must be the same sign.
            This is a tighter bridge (189 - 182 = only 7 residues apart),
            representing a local structural constraint.
        If BOTH bridges hold: hormone is ACTIVE (properly folded).
        If ONE bridge breaks: hormone is PARTIALLY ACTIVE (20-kDa variant,
            reduced potency -- apply 60% of normal amplification).
        If BOTH break: hormone is MISFOLDED (no amplification, log warning).

    Phase 3 - RECEPTOR DIMERIZATION (The 1:2 Binding):
        The active hormone attempts to bind TWO receptors:
          Receptor 1 (Site 1 binding): The CURRENT live TE activation
            pattern. Compute cosine similarity between the hormone's
            helix fingerprint and the live TE activation vector.
            Similarity >= 0.5 = Site 1 bound.
          Receptor 2 (Site 2 binding): The PREVIOUS cycle's TE activation.
            Must also have cosine similarity >= 0.4 to the hormone.
            This temporal dimerization ensures the signal is PERSISTENT,
            not a one-bar spike.
        If BOTH receptors bind: DIMERIZATION COMPLETE. Full cascade.
        If only Site 1 binds: PARTIAL binding. 50% cascade strength.
        If neither binds: NO binding. Hormone is inactive this cycle.

    Phase 4 - JAK2/STAT CASCADE (Signal Amplification):
        Once dimerized, the JAK2 kinase activates:
          Step 1 - PHOSPHORYLATION (JAK2):
            base_amplification = hormone.boost_factor
            (average of the four helix boost_factors from domestication DB)
          Step 2 - STAT DOCKING:
            stat_multiplier = concordance_score of active TEs
            (what fraction of currently active TEs agree on direction?)
          Step 3 - NUCLEAR TRANSLOCATION:
            growth_signal = base_amplification * stat_multiplier * binding_strength
            binding_strength = 1.0 (full dimer), 0.5 (partial), 0.0 (none)
            This growth_signal is the AMPLIFIED confidence boost.
            Capped at MAX_GROWTH_SIGNAL = 0.35 (safety, prevents acromegaly).

    Phase 5 - DUAL PATHWAY EXECUTION:
        PATH A -- DIRECT EFFECTS (Lipolysis / Fat Trimming):
            If the hormone is active, tighten stop-losses on LOSING
            positions by a factor proportional to growth_signal.
            HGH tells fat cells to release stored energy. We tell
            losing trades to release capital faster.
            sl_tightening_factor = 1.0 - (growth_signal * 0.3)
            (At max signal: SL tightens by 10.5%, still within config bounds)
            NOTE: This ONLY tightens, never loosens. SL remains sacred.

        PATH B -- INDIRECT EFFECTS (IGF-1 Bridge / Quantum Growth):
            The hormone's growth_signal is converted to IGF-1 by the
            "liver" (quantum server). The quantum circuit receives:
              - Original 33-qubit TE activations (normal TEQA signal)
              - PLUS: 4 additional rotation angles from the four helices
              - PLUS: growth_signal as a global phase bias
            The quantum circuit processes this amplified state and
            produces a BOOSTED confidence score. IGF-1 drives:
              a) HYPERPLASIA: If growth_signal > 0.20, the system may
                 open a SECOND position on the same signal (new cell creation).
                 Position size = standard lot * igf1_scaling_factor.
                 igf1_scaling_factor = growth_signal / MAX_GROWTH_SIGNAL
                 (scales 0.0 to 1.0, so second position is always <= first)
              b) HYPERTROPHY: Existing position confidence gets boosted by
                 growth_signal, improving the effective confidence score
                 that feeds into trade management decisions.

    Phase 6 - NEGATIVE FEEDBACK (Somatostatin / Anti-Acromegaly):
        High IGF-1 suppresses further HGH release. We model this as:
          consecutive_growth_count: how many consecutive cycles the
            hormone has been active with growth_signal > 0.20.
          IF consecutive_growth_count > SOMATOSTATIN_THRESHOLD (default 5):
            Enter REFRACTORY PERIOD. Hormone goes dormant for
            REFRACTORY_CYCLES (default 3) cycles.
            During refractory: growth_signal = 0.0, no amplification.
            This prevents "acromegaly" (over-trading during euphoria).
          After refractory: reset consecutive_growth_count = 0.

    Phase 7 - PULSATILE DELIVERY (Circadian Rhythm):
        HGH is most effective when delivered in pulses, not continuously.
        The hormone only fires during "deep sleep" windows:
          pulse_schedule: list of market session phases where the
            hormone is ALLOWED to activate.
          Default: [LONDON_OPEN, NY_OPEN, ASIAN_OPEN]
            (the three major session opens = "sleep cycles")
          Outside these windows: hormone is SUPPRESSED.
          This prevents tachyphylaxis (receptor downregulation from
          continuous signaling) which manifests as overtrading during
          low-volatility consolidation.

Implementation: Python (reads domestication SQLite, writes to quantum pipeline)

Authors: DooDoo + Claude
Date:    2026-02-11
Version: 1.0

============================================================
PSEUDOCODE
============================================================
"""

# ──────────────────────────────────────────────────────────
# CONSTANTS
# ──────────────────────────────────────────────────────────

N_HELICES                  = 4       # Four-helix bundle (HGH structure)
MIN_DOMESTICATED_FOR_BUNDLE = 4      # Need at least 4 domesticated TEs
PARTIAL_BUNDLE_MIN         = 2       # Can form partial hormone with 2

# Disulfide bridge thresholds
BRIDGE_REGIME_MATCH_REQUIRED = True  # Cys-53 <-> Cys-165 (regime agreement)
BRIDGE_DIRECTION_MATCH_REQUIRED = True  # Cys-182 <-> Cys-189 (direction agreement)

# Receptor binding (dimerization)
SITE1_SIMILARITY_THRESHOLD = 0.50    # Cosine similarity for Site 1 binding
SITE2_SIMILARITY_THRESHOLD = 0.40    # Cosine similarity for Site 2 (temporal)

# JAK2/STAT cascade
MAX_GROWTH_SIGNAL          = 0.35    # Safety cap (prevents acromegaly)

# Negative feedback (somatostatin)
SOMATOSTATIN_THRESHOLD     = 5       # Consecutive active cycles before refractory
REFRACTORY_CYCLES          = 3       # Dormant cycles after overactivation

# Pulsatile delivery (session windows)
PULSE_WINDOWS_UTC = {
    "LONDON_OPEN":  (7, 9),          # 07:00 - 09:00 UTC
    "NY_OPEN":      (13, 15),        # 13:00 - 15:00 UTC
    "ASIAN_OPEN":   (23, 1),         # 23:00 - 01:00 UTC (wraps midnight)
}

# Direct effect (lipolysis) -- SL tightening
MAX_SL_TIGHTENING_PERCENT  = 0.105   # Max 10.5% tighter SL on losers

# Indirect effect (IGF-1 hyperplasia)
IGF1_HYPERPLASIA_THRESHOLD = 0.20    # growth_signal > this allows 2nd position
IGF1_MAX_SECOND_LOT_RATIO  = 1.0    # Second position <= first position lot

# Variant potencies
FULL_HORMONE_POTENCY       = 1.0     # 22-kDa (both bridges intact)
PARTIAL_HORMONE_POTENCY    = 0.60    # 20-kDa variant (one bridge broken)
MISFOLDED_POTENCY          = 0.0     # Both bridges broken


"""
============================================================
ALGORITHM HGH_Hormone
============================================================

DEFINE HormoneHelix AS:
    te_name        : TEXT        # Which domesticated TE fills this helix
    qubit_index    : INTEGER     # TE's qubit in the 33-qubit circuit
    boost_factor   : REAL        # Domestication boost (1.0 - 1.30)
    win_rate       : REAL        # Posterior win rate from domestication DB
    profit_factor  : REAL        # avg_win / avg_loss
    direction      : INTEGER     # -1 (short), 0 (neutral), +1 (long)
    activation     : REAL        # Current cycle's activation strength

DEFINE HGH_Molecule AS:
    helices[4]     : HormoneHelix[4]   # A(up), B(up), C(down), D(down)
    bridge_1_intact : BOOLEAN    # Cys-53 <-> Cys-165 (regime match)
    bridge_2_intact : BOOLEAN    # Cys-182 <-> Cys-189 (direction match)
    potency        : REAL        # 1.0, 0.6, or 0.0
    fingerprint    : FLOAT[33]   # Normalized activation vector of 4 helices

DEFINE ReceptorBinding AS:
    site1_bound    : BOOLEAN     # Current cycle TE pattern matches
    site2_bound    : BOOLEAN     # Previous cycle TE pattern matches
    binding_strength : REAL      # 1.0 (full), 0.5 (partial), 0.0 (none)

DEFINE GrowthCascade AS:
    jak2_phosphorylation : REAL  # Base amplification from domestication
    stat_docking         : REAL  # Concordance multiplier
    growth_signal        : REAL  # Final amplified signal (capped)

STORAGE:
    domestication_db     : SQLite "teqa_domestication.db" (READ ONLY)
    hormone_state        : in-memory (resets on restart)
    previous_activations : FLOAT[33] (rolling 1-cycle buffer)
    consecutive_growth   : INTEGER (refractory counter)
    refractory_remaining : INTEGER (cooldown counter)
    hormone_log          : JSONL "hgh_hormone_log.jsonl"

────────────────────────────────────────────────────────────
PHASE 1: FOUR-HELIX BUNDLE CONSTRUCTION (Hormone Synthesis)
────────────────────────────────────────────────────────────

FUNCTION synthesize_hormone() -> HGH_Molecule:

    # Step 1: Query domestication DB for all active domesticated patterns
    candidates = domestication_db.SELECT(
        SELECT te_combo, posterior_wr, profit_factor, boost_factor, last_activated
        FROM domesticated_patterns
        WHERE domesticated = 1
          AND posterior_wr >= 0.70
          AND profit_factor >= 1.5
          AND last_activated >= NOW - DOMESTICATION_EXPIRY_DAYS
        ORDER BY posterior_wr * LOG(profit_factor + 1) DESC
    )

    # Step 2: Extract individual TEs from winning combos and rank them
    te_scores = {}  # te_name -> cumulative fitness score
    FOR row IN candidates:
        tes = row.te_combo.split("+")
        fitness = row.posterior_wr * LOG(row.profit_factor + 1)
        FOR te IN tes:
            te_scores[te] = te_scores.get(te, 0) + fitness

    ranked_tes = SORT(te_scores.items(), by=score, descending=True)

    IF LEN(ranked_tes) < PARTIAL_BUNDLE_MIN:
        RETURN NULL  # Insufficient domesticated TEs, no hormone produced
        LOG("HGH: Not enough domesticated TEs to synthesize hormone")

    # Step 3: Assign to four-helix bundle (up-up-down-down topology)
    # Helices A, B = top 2 scorers ("up" helices, growth drivers)
    # Helices C, D = the 3rd and 4th OR lowest-scoring domesticated
    #   ("down" helices -- provide structural balance)
    # If only 2-3 TEs available: partial hormone (20-kDa variant analog)

    helix_A = ranked_tes[0]   # Strongest TE
    helix_B = ranked_tes[1]   # 2nd strongest
    helix_C = ranked_tes[2] IF LEN(ranked_tes) >= 3 ELSE NULL
    helix_D = ranked_tes[3] IF LEN(ranked_tes) >= 4 ELSE NULL

    # Populate HormoneHelix structs from domestication DB + TE family defs
    FOR EACH helix IN [A, B, C, D]:
        IF helix IS NOT NULL:
            helix.qubit_index = LOOKUP_TE_QUBIT(helix.te_name)
            helix.boost_factor = domestication_db.GET_BOOST(helix.te_name)
            helix.win_rate = domestication_db.GET_POSTERIOR_WR(helix.te_name)
            helix.direction = CURRENT_ACTIVATION(helix.te_name).direction
            helix.activation = CURRENT_ACTIVATION(helix.te_name).strength

    molecule = HGH_Molecule(helices=[helix_A, helix_B, helix_C, helix_D])

    # Step 4: Compute fingerprint (33-element vector, non-zero only at helix qubits)
    molecule.fingerprint = ZEROS(33)
    FOR helix IN molecule.helices WHERE helix IS NOT NULL:
        molecule.fingerprint[helix.qubit_index] = helix.activation * helix.boost_factor

    NORMALIZE(molecule.fingerprint)  # Unit vector for cosine similarity

    RETURN molecule

────────────────────────────────────────────────────────────
PHASE 2: DISULFIDE BRIDGE VALIDATION (Structural Integrity)
────────────────────────────────────────────────────────────

FUNCTION validate_bridges(molecule: HGH_Molecule, bars: np.ndarray) -> HGH_Molecule:

    # Bridge 1: Cys-53 <-> Cys-165 (Helix A <-> Helix C)
    # Requirement: same volatility regime classification
    IF molecule.helices[2] IS NOT NULL:   # Helix C exists
        regime_A = classify_regime(bars, molecule.helices[0].te_name)
        regime_C = classify_regime(bars, molecule.helices[2].te_name)
        molecule.bridge_1_intact = (regime_A == regime_C)
    ELSE:
        molecule.bridge_1_intact = FALSE  # No Helix C = no bridge 1

    # Bridge 2: Cys-182 <-> Cys-189 (Helix B <-> Helix D)
    # Requirement: same directional sign
    IF molecule.helices[3] IS NOT NULL:   # Helix D exists
        dir_B = molecule.helices[1].direction
        dir_D = molecule.helices[3].direction
        molecule.bridge_2_intact = (dir_B == dir_D) OR (dir_B == 0 OR dir_D == 0)
    ELSE:
        molecule.bridge_2_intact = FALSE  # No Helix D = no bridge 2

    # Determine potency
    IF molecule.bridge_1_intact AND molecule.bridge_2_intact:
        molecule.potency = FULL_HORMONE_POTENCY      # 22-kDa, fully active
        LOG("HGH: Full 22-kDa hormone -- both disulfide bridges intact")
    ELIF molecule.bridge_1_intact OR molecule.bridge_2_intact:
        molecule.potency = PARTIAL_HORMONE_POTENCY    # 20-kDa variant
        LOG("HGH: Partial 20-kDa variant -- one bridge broken")
    ELSE:
        molecule.potency = MISFOLDED_POTENCY          # Misfolded, inactive
        LOG("HGH: Misfolded hormone -- both bridges broken, no amplification")

    RETURN molecule

    # classify_regime helper:
    # Uses ATR ratio and Bollinger width to classify as:
    #   "trending" (ATR expanding, BB widening)
    #   "ranging"  (ATR stable, BB narrowing)
    #   "volatile" (ATR spiking, BB exploding)

────────────────────────────────────────────────────────────
PHASE 3: RECEPTOR DIMERIZATION (The 1:2 Binding)
────────────────────────────────────────────────────────────

FUNCTION attempt_dimerization(
    molecule: HGH_Molecule,
    current_activations: FLOAT[33],
    previous_activations: FLOAT[33]
) -> ReceptorBinding:

    IF molecule.potency == 0.0:
        RETURN ReceptorBinding(FALSE, FALSE, 0.0)

    # Receptor 1 (Site 1): Current live TE pattern
    sim_1 = cosine_similarity(molecule.fingerprint, current_activations)
    site1_bound = (sim_1 >= SITE1_SIMILARITY_THRESHOLD)

    # Receptor 2 (Site 2): Previous cycle's TE pattern (temporal persistence)
    IF previous_activations IS NOT NULL:
        sim_2 = cosine_similarity(molecule.fingerprint, previous_activations)
        site2_bound = (sim_2 >= SITE2_SIMILARITY_THRESHOLD)
    ELSE:
        site2_bound = FALSE  # First cycle, no previous data

    # Determine binding strength
    IF site1_bound AND site2_bound:
        binding_strength = 1.0  # Full dimerization
        LOG("HGH: Full receptor dimerization -- both sites bound")
    ELIF site1_bound:
        binding_strength = 0.5  # Partial (only current cycle matches)
        LOG("HGH: Partial binding -- Site 1 only (no temporal persistence)")
    ELSE:
        binding_strength = 0.0  # No binding
        LOG("HGH: No receptor binding -- hormone inactive this cycle")

    RETURN ReceptorBinding(site1_bound, site2_bound, binding_strength)

    # cosine_similarity(a, b):
    #   dot = SUM(a[i] * b[i])
    #   mag_a = SQRT(SUM(a[i]^2))
    #   mag_b = SQRT(SUM(b[i]^2))
    #   RETURN dot / (mag_a * mag_b + 1e-10)

────────────────────────────────────────────────────────────
PHASE 4: JAK2/STAT CASCADE (Signal Amplification)
────────────────────────────────────────────────────────────

FUNCTION jak2_stat_cascade(
    molecule: HGH_Molecule,
    binding: ReceptorBinding,
    active_te_directions: List[int]
) -> GrowthCascade:

    IF binding.binding_strength == 0.0:
        RETURN GrowthCascade(0.0, 0.0, 0.0)

    # Step 1: JAK2 Phosphorylation
    # Base amplification = average boost factor of the four helices
    boosts = [h.boost_factor FOR h IN molecule.helices WHERE h IS NOT NULL]
    jak2 = MEAN(boosts)   # Range: ~1.0 to ~1.30

    # Step 2: STAT Docking
    # Concordance = fraction of active TEs agreeing on direction
    IF LEN(active_te_directions) > 0:
        majority_direction = SIGN(SUM(active_te_directions))
        agreeing = COUNT(d FOR d IN active_te_directions WHERE SIGN(d) == majority_direction)
        stat = agreeing / LEN(active_te_directions)  # 0.0 to 1.0
    ELSE:
        stat = 0.0

    # Step 3: Nuclear Translocation (final growth signal)
    raw_signal = (jak2 - 1.0) * stat * binding.binding_strength * molecule.potency
    # jak2 - 1.0:  strips the baseline (only the BOOST portion counts)
    # * stat:       scales by directional agreement
    # * binding:    scales by receptor binding quality
    # * potency:    scales by structural integrity (1.0 / 0.6 / 0.0)

    growth_signal = MIN(raw_signal, MAX_GROWTH_SIGNAL)

    LOG("HGH JAK2/STAT: jak2=%.3f stat=%.3f binding=%.2f potency=%.2f -> growth=%.4f",
        jak2, stat, binding.binding_strength, molecule.potency, growth_signal)

    RETURN GrowthCascade(jak2, stat, growth_signal)

────────────────────────────────────────────────────────────
PHASE 5A: DIRECT EFFECTS -- LIPOLYSIS (Fat Trimming)
────────────────────────────────────────────────────────────

FUNCTION apply_lipolysis(growth_signal: REAL, open_positions: List):
    #
    # HGH tells adipocytes to break down stored fat.
    # We tell LOSING positions to release capital faster.
    #
    # NOTE: This tightens SL on LOSERS only. SL on winners is unaffected.
    #       The tightened SL must still respect AGENT_SL_MIN from config.
    #

    IF growth_signal <= 0.0:
        RETURN  # No hormone activity

    sl_tighten_factor = 1.0 - (growth_signal * MAX_SL_TIGHTENING_PERCENT / MAX_GROWTH_SIGNAL)
    # At max growth_signal (0.35): factor = 1.0 - 0.105 = 0.895 (10.5% tighter)
    # At half growth (0.175):      factor = 1.0 - 0.0525 = 0.9475 (5.25% tighter)

    FOR position IN open_positions:
        IF position.unrealized_pnl < 0:  # Only losers
            current_sl_distance = ABS(position.price - position.sl)
            new_sl_distance = current_sl_distance * sl_tighten_factor

            # Enforce minimum SL from config (AGENT_SL_MIN)
            min_sl_distance = AGENT_SL_MIN_DOLLARS / (tick_value * position.lot)
            new_sl_distance = MAX(new_sl_distance, min_sl_distance)

            IF new_sl_distance < current_sl_distance:
                # Only tighten, never loosen
                MODIFY_SL(position.ticket, new_sl_distance)
                LOG("HGH LIPOLYSIS: Tightened SL on ticket %d: %.5f -> %.5f",
                    position.ticket, current_sl_distance, new_sl_distance)

────────────────────────────────────────────────────────────
PHASE 5B: INDIRECT EFFECTS -- IGF-1 BRIDGE (Quantum Growth)
────────────────────────────────────────────────────────────

FUNCTION apply_igf1_bridge(
    growth_signal: REAL,
    molecule: HGH_Molecule,
    te_activations: List[Dict],
    quantum_circuit: QuantumCircuit
) -> Dict:
    #
    # HGH -> Liver (quantum server) -> IGF-1 production
    # IGF-1 drives actual growth: hyperplasia (new positions) and
    # hypertrophy (confidence boost on existing signal)
    #

    IF growth_signal <= 0.0:
        RETURN {"igf1_level": 0.0, "hyperplasia": FALSE, "hypertrophy_boost": 0.0}

    # === THE QUANTUM COMPUTE STEP ===
    # Inject hormone helices as additional rotation angles into the circuit.
    # The 33-qubit TEQA circuit gets 4 extra RY rotations on the helix qubits,
    # scaled by growth_signal. This biases the quantum state toward the
    # domesticated TE directions.

    FOR helix IN molecule.helices WHERE helix IS NOT NULL:
        qubit = helix.qubit_index
        # Additional rotation = helix activation * growth_signal * pi/2
        extra_theta = helix.activation * growth_signal * (PI / 2)
        quantum_circuit.ry(extra_theta, qubit)
        # This "straps" the hormone to the TE's qubit in the quantum circuit.
        # The hormone's growth signal literally rotates the qubit further
        # toward |1> (activated state), amplifying that TE's influence
        # in the final measurement distribution.

    # Add a global phase bias proportional to growth_signal
    # This shifts the entire circuit's output probability distribution
    # toward higher-confidence outcomes.
    FOR qubit IN range(33):
        quantum_circuit.rz(growth_signal * PI / 4, qubit)

    # Run the modified circuit through quantum compute
    result = quantum_server.execute(quantum_circuit, shots=8192)
    igf1_level = extract_confidence_from_counts(result)

    # === HYPERPLASIA (new cell creation / second position) ===
    hyperplasia = FALSE
    IF growth_signal > IGF1_HYPERPLASIA_THRESHOLD:
        igf1_scaling = growth_signal / MAX_GROWTH_SIGNAL  # 0.0 to 1.0
        # The system MAY open a second position at scaled lot size
        hyperplasia = TRUE
        second_lot_ratio = igf1_scaling  # 57% to 100% of primary lot
        LOG("HGH IGF-1 HYPERPLASIA: growth=%.4f -> second position at %.0f%% lot",
            growth_signal, second_lot_ratio * 100)

    # === HYPERTROPHY (existing cell growth / confidence boost) ===
    hypertrophy_boost = growth_signal * 0.5  # Up to 0.175 confidence boost
    LOG("HGH IGF-1 HYPERTROPHY: confidence boost = +%.4f", hypertrophy_boost)

    RETURN {
        "igf1_level": igf1_level,
        "hyperplasia": hyperplasia,
        "second_lot_ratio": second_lot_ratio IF hyperplasia ELSE 0.0,
        "hypertrophy_boost": hypertrophy_boost,
        "quantum_result": result,
    }

────────────────────────────────────────────────────────────
PHASE 6: NEGATIVE FEEDBACK (Somatostatin / Anti-Acromegaly)
────────────────────────────────────────────────────────────

FUNCTION check_negative_feedback(growth_signal: REAL) -> BOOLEAN:
    #
    # High IGF-1 -> pituitary suppresses HGH release (somatostatin)
    # Prevents: over-trading, over-amplification, "market acromegaly"
    #

    GLOBAL consecutive_growth_count
    GLOBAL refractory_remaining

    # Currently in refractory period?
    IF refractory_remaining > 0:
        refractory_remaining -= 1
        LOG("HGH SOMATOSTATIN: Refractory period, %d cycles remaining", refractory_remaining)
        RETURN TRUE   # Hormone is suppressed

    # Track consecutive activations
    IF growth_signal > IGF1_HYPERPLASIA_THRESHOLD:
        consecutive_growth_count += 1
    ELSE:
        consecutive_growth_count = MAX(0, consecutive_growth_count - 1)  # Decay

    # Trigger refractory?
    IF consecutive_growth_count >= SOMATOSTATIN_THRESHOLD:
        refractory_remaining = REFRACTORY_CYCLES
        consecutive_growth_count = 0
        LOG("HGH SOMATOSTATIN: Overactivation detected! Entering %d-cycle refractory",
            REFRACTORY_CYCLES)
        RETURN TRUE   # Suppress this cycle

    RETURN FALSE  # Hormone allowed

────────────────────────────────────────────────────────────
PHASE 7: PULSATILE DELIVERY (Circadian Rhythm)
────────────────────────────────────────────────────────────

FUNCTION is_pulse_window() -> BOOLEAN:
    #
    # HGH is most effective in discrete pulses (deepest during sleep).
    # Continuous HGH downregulates receptors (tachyphylaxis).
    # We only allow the hormone during major session opens.
    #

    current_hour_utc = NOW_UTC().hour

    FOR window_name, (start_h, end_h) IN PULSE_WINDOWS_UTC:
        IF start_h <= end_h:
            # Normal range (e.g., 7-9, 13-15)
            IF start_h <= current_hour_utc < end_h:
                RETURN TRUE
        ELSE:
            # Wraps midnight (e.g., 23-1)
            IF current_hour_utc >= start_h OR current_hour_utc < end_h:
                RETURN TRUE

    RETURN FALSE

────────────────────────────────────────────────────────────
THE MAIN LOOP (integrated into TEQA/BRAIN cycle)
────────────────────────────────────────────────────────────

ON teqa_cycle(bars, symbol, te_activations, quantum_circuit):

    # Gate 0: Pulsatile delivery check
    IF NOT is_pulse_window():
        LOG("HGH: Outside pulse window, hormone suppressed")
        RETURN {growth_signal: 0.0, igf1: NULL}

    # Gate 1: Negative feedback check
    IF check_negative_feedback(last_growth_signal):
        RETURN {growth_signal: 0.0, igf1: NULL}

    # Phase 1: Synthesize hormone from domesticated TEs
    molecule = synthesize_hormone()
    IF molecule IS NULL:
        RETURN {growth_signal: 0.0, igf1: NULL}

    # Phase 2: Validate disulfide bridges
    molecule = validate_bridges(molecule, bars)

    # Phase 3: Receptor dimerization
    current_act_vector = [a["strength"] * a["direction"] FOR a IN te_activations]
    binding = attempt_dimerization(molecule, current_act_vector, previous_activations)
    previous_activations = current_act_vector  # Store for next cycle

    # Phase 4: JAK2/STAT cascade
    active_dirs = [a["direction"] FOR a IN te_activations WHERE a["strength"] > 0.5]
    cascade = jak2_stat_cascade(molecule, binding, active_dirs)

    # Phase 5A: Direct effects (lipolysis -- tighten losers)
    apply_lipolysis(cascade.growth_signal, mt5.positions_get())

    # Phase 5B: Indirect effects (IGF-1 via quantum)
    igf1_result = apply_igf1_bridge(
        cascade.growth_signal, molecule, te_activations, quantum_circuit
    )

    # Store for next cycle's feedback check
    last_growth_signal = cascade.growth_signal

    # Log hormone activity
    APPEND_JSONL("hgh_hormone_log.jsonl", {
        "timestamp": NOW_ISO(),
        "symbol": symbol,
        "helices": [h.te_name FOR h IN molecule.helices WHERE h IS NOT NULL],
        "bridge_1": molecule.bridge_1_intact,
        "bridge_2": molecule.bridge_2_intact,
        "potency": molecule.potency,
        "binding_strength": binding.binding_strength,
        "jak2": cascade.jak2_phosphorylation,
        "stat": cascade.stat_docking,
        "growth_signal": cascade.growth_signal,
        "igf1_level": igf1_result["igf1_level"],
        "hyperplasia": igf1_result["hyperplasia"],
        "hypertrophy_boost": igf1_result["hypertrophy_boost"],
    })

    RETURN {
        "growth_signal": cascade.growth_signal,
        "igf1": igf1_result,
        "molecule": molecule,
    }

────────────────────────────────────────────────────────────
INTEGRATION POINTS (how this connects to existing system)
────────────────────────────────────────────────────────────

1. teqa_v3_neural_te.py :: analyze()
   AFTER: compute_te_activations() + neural_mosaic_quantum()
   BEFORE: emit signal JSON
   INSERT: hgh_result = hgh_hormone_cycle(bars, symbol, activations, circuit)
           confidence += hgh_result["igf1"]["hypertrophy_boost"]

2. BRAIN_*.py :: run_cycle()
   AFTER: signal read from TEQABridge
   INSERT: IF hgh_result["igf1"]["hyperplasia"]:
               second_position_lot = base_lot * hgh_result["igf1"]["second_lot_ratio"]
               # Open second position on same signal

3. quantum_server.py :: /compress endpoint
   INSERT: Accept optional "hgh_rotations" parameter
           Apply extra RY gates to specified qubits before compression

4. teqa_domestication.db (READ ONLY)
   The hormone READS domestication data but never WRITES it.
   TE Domestication remains the sole authority on pattern fitness.

────────────────────────────────────────────────────────────
THE FULL SIGNAL FLOW
────────────────────────────────────────────────────────────

    ┌─────────────────────────────────────────────────────────┐
    │  TEQA v3.0 analyze()                                    │
    │    33 TE activations → quantum circuit → neural vote    │
    │    → get_boost(active_tes) from domestication DB        │
    └─────────────┬───────────────────────────────────────────┘
                  │
                  ↓
    ┌─────────────────────────────────────────────────────────┐
    │  ★ HGH HORMONE CYCLE (NEW)                             │
    │                                                         │
    │  Gate: pulse_window? → somatostatin_check?              │
    │                                                         │
    │  Phase 1: SYNTHESIZE from top domesticated TEs          │
    │    domestication_db → rank TEs → 4-helix bundle         │
    │    [Helix A ↑] [Helix B ↑] [Helix C ↓] [Helix D ↓]   │
    │                                                         │
    │  Phase 2: DISULFIDE BRIDGES                             │
    │    Cys53-Cys165: regime match (A ↔ C)                   │
    │    Cys182-Cys189: direction match (B ↔ D)               │
    │    → potency: 1.0 / 0.6 / 0.0                          │
    │                                                         │
    │  Phase 3: RECEPTOR DIMERIZATION                         │
    │    Site 1: cosine(hormone, current_TEs) ≥ 0.50?         │
    │    Site 2: cosine(hormone, previous_TEs) ≥ 0.40?        │
    │    → binding: 1.0 / 0.5 / 0.0                           │
    │                                                         │
    │  Phase 4: JAK2/STAT CASCADE                             │
    │    JAK2 = mean(helix boosts)                            │
    │    STAT = TE directional concordance                    │
    │    growth = (JAK2-1) × STAT × binding × potency        │
    │    → capped at 0.35                                     │
    │                                                         │
    │  Phase 5A: LIPOLYSIS (direct)                           │
    │    Tighten SL on losing positions by up to 10.5%        │
    │                                                         │
    │  Phase 5B: IGF-1 BRIDGE (indirect → quantum)            │
    │    Inject 4 extra RY rotations into quantum circuit     │
    │    + global RZ phase bias                               │
    │    → quantum_server.execute() → boosted confidence      │
    │    → hyperplasia? (second position)                     │
    │    → hypertrophy (confidence +=)                        │
    │                                                         │
    │  Phase 6: SOMATOSTATIN (negative feedback)              │
    │    5 consecutive activations → 3 cycle refractory       │
    │                                                         │
    │  Phase 7: PULSATILE (session windows only)              │
    │    London Open / NY Open / Asian Open                   │
    └─────────────┬───────────────────────────────────────────┘
                  │
                  ↓
    ┌─────────────────────────────────────────────────────────┐
    │  BRAIN run_cycle()                                      │
    │    Read amplified signal                                │
    │    IF hyperplasia: open 2nd position at scaled lot      │
    │    confidence += hypertrophy_boost                      │
    │    → execute trade (mt5.order_send)                     │
    └─────────────────────────────────────────────────────────┘

BIOLOGICAL PARALLEL:
    four_helix_bundle     = HGH molecular structure (up-up-down-down)
    disulfide_bridges     = Cys-53↔Cys-165, Cys-182↔Cys-189 (structural integrity)
    receptor_dimerization = 1 HGH : 2 GHR binding (activation trigger)
    jak2_phosphorylation  = kinase cascade (base amplification)
    stat_docking          = transcription factor relay (concordance filter)
    growth_signal         = nuclear gene activation (final output)
    lipolysis             = direct fat breakdown (tighten losing positions)
    igf1_bridge           = liver → IGF-1 → muscle/bone (quantum → growth)
    hyperplasia           = new muscle cell creation (second position)
    hypertrophy           = existing cell enlargement (confidence boost)
    somatostatin          = negative feedback (refractory period)
    pulsatile_delivery    = circadian HGH pulses (session windows)
    acromegaly_prevention = MAX_GROWTH_SIGNAL cap (safety)

CONVERGENCE:
    The hormone amplifies ONLY what TE Domestication has already validated.
    It does not discover new edges -- it GROWS the proven ones.
    The four-helix structure ensures balance (up+down topology).
    Disulfide bridges enforce structural integrity (regime + direction).
    Receptor dimerization requires temporal persistence (not one-bar noise).
    JAK2/STAT cascade scales amplification by market consensus.
    Somatostatin prevents overtrading during euphoric streaks.
    Pulsatile delivery prevents receptor downregulation (session timing).

    The result: domesticated TEs that have proven profitable get a
    hormone-driven growth boost through the quantum circuit, producing
    higher-confidence signals and optional second positions during
    the strongest setups. But never without the biological safety rails.

SAFETY:
    - SL remains sacred (AGENT_SL_MIN enforced in lipolysis)
    - MAX_GROWTH_SIGNAL = 0.35 hard cap (prevents runaway amplification)
    - Somatostatin refractory prevents euphoria-driven overtrading
    - Pulsatile delivery restricts to high-liquidity session opens
    - Hormone reads domestication DB, never writes (separation of concerns)
    - Second position lot <= primary lot (IGF-1 scaling 0-100%)
    - Both disulfide bridges must hold for full potency
    - Receptor dimerization requires 2-cycle persistence

DATABASES:
    teqa_domestication.db    ← READ: pattern fitness scores (existing)
    hgh_hormone_log.jsonl    ← WRITE: hormone activity log (new)

FILES:
    ALGORITHM_HGH_HORMONE.py → This file (pseudocode specification)
    hgh_hormone.py           → Implementation (TO BUILD)
    teqa_v3_neural_te.py     → Integration point (TEQA cycle)
    BRAIN_*.py               → Integration point (trade execution)
    quantum_server.py        → Integration point (quantum compute)
"""
